Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
125 hedge funds and large institutions have $999M invested in Silk Road Medical, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 50 increasing their positions, 42 reducing their positions, and 23 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 42
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 130 → 125 (-5)
13% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 23
15% less capital invested
Capital invested by funds: $1.18B → $999M (-$182M)
61% less call options, than puts
Call options by funds: $881K | Put options by funds: $2.25M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$70.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$40.1M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$30.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$24.4M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$12.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$86.3M |
| 2 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$19.7M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$11.7M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$10.3M |
| 5 |
AI
Atom Investors
Austin,
Texas
|
-$7.58M |
SILK Hedge Fund Activity: Q1 2020 in Review
125 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q1 2020, worth a combined $999M — down 15% from $1.18B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of SILK and 20 opened new positions — a net loss of 3 holders — while 42 trimmed existing stakes and 50 added.
The largest buyer was Capital World Investors, opening a new position worth an estimated $70.8M. The largest seller was Wells Fargo, cutting an estimated $86.3M.
- 125 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q1 2020, down from 130 in Q4 2019.
- Funds reported $999M of Silk Road Medical, Inc. Common Stock stock for Q1 2020, down 15% quarter-over-quarter.
- 20 funds opened new Silk Road Medical, Inc. Common Stock positions in Q1 2020 and 23 closed out, a net change of -3 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q1 2020 was Capital World Investors, an estimated $70.8M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q1 2020 was Wells Fargo, an estimated $86.3M sold.
Based on aggregated 13F filings for Q1 2020.